References
- Ambrogi V., Bloch K., Daturi S., Griggi P., Logemann W., Parenti M. A., Rabini T., Tommasini R. New oral antidiabetic drugs. Part I. Arzneim-forsch 1971; 21: 200–2041. Ambrogi V., Bloch K., Daturi S., Griggi P., Logemann W., Parenti M. A., Rabini T., Tommasini R. New oral antidiabetic drugs. Part I. Arzneim-forsch 1971; 21: 200–204
- Ambrogi V., Bloch K., Cozzi P., Daturi S., Logemann W., Parenti M. A., Tommasini R. New oral antidiabetic drugs. Part II. Arzneim-forsch 1971; 21: 204–2082. Ambrogi V., Bloch K., Cozzi P., Daturi S., Logemann W., Parenti M. A., Tommasini R. New oral antidiabetic drugs. Part II. Arzneim-forsch 1971; 21: 204–208
- Parodi F. A. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K4024. Israel J. med. Sci 1972; 8: 888–8923. Parodi F. A. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K4024. Israel J. med. Sci 1972; 8: 888–892